Thank you for visiting my fundraising page!  I'm raising funds for EGFR research with EGFR Resisters benefitting the Lung Cancer Research Foundation.  

100% of the money you donate to this particular fundraiser will be used for lifesaving research focused on making surviving EGFR lung cancer the expectation, not the exception!

In March of this year, I was diagnosed with Stage IV metastatic lung cancer that has spread to my brain, spine and adrenal glands.  My only symptoms were a lingering cough and shortness of breath in late January and February.  This should just not happen to people.  Lung cancer kills more than colon, breast and prostate cancer combined!  Yet awareness and funding for lung cancer research are incredibly low compared to other types of cancer. More research needs to be done to develop screenings to diagnose lung cancer sooner and treat it.

The research that has already been done has developed the drug I'm currently on but the drug will wear off - on average in 18 months.  I will need another drug to treat my lung cancer after that.  There is so much hope on the horizon but funding is needed for the research to happen and new drugs to be developed.  My life depends on it at this point.

You have the power to give my family, me and others with EGFR lung cancer hope when faced with this devastating diagnosis.

From the bottom of my heart, thank you for your support and generosity!

More about EGFR lung cancer:

EGFR is a protein expressed on the surface of cells and its job is to help cells grow and divide. In the case of EGFR-positive non small cell lung cancer (NSCLC), a mutation, or damage, in the EGFR gene causes the EGFR protein to remain stuck in the “on” position. This “drives” abnormal cell growth, which is what cancer is.

EGFR-positive lung cancer is more common in certain populations, such as

• people who have never smoked or only smoked a little
• people with lung adenocarcinoma
• women
• young adults with lung cancer (EGFR mutations are present in roughly 50
  percent of lung cancers in young adults)
• people of Asian or East Asian heritage

EGFR-positive lung cancer represents about 10-15% of lung cancer in the United States